A study of STX-721/PFL-721 in participants with non-small cell lung cancer with certain mutations
PFL721CI101
Phase 2 other active
Quick answer
A study of STX-721/PFL-721 in participants with non-small cell lung cancer with certain mutations for Locally Advanced or Metastatic Non-Small Cell Lung Cancer is a Phase 2 program (other) at Pierre Fabre Medicament with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pierre Fabre Medicament
- Indication
- Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Phase
- Phase 2
- Modality
- other
- Status
- active